GoodRx Inc.
GDRX | NASDAQ
$3.40
+$0.01 (+0.29%)
Sep 22, 2026, 2:43 PM ET · Market open
Company Profile
GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States. Beyond this core offering, the firm also extends its portfolio to include subscription services, programs designed for pharmaceutical manufacturers, and telehealth capabilities. GoodRx additionally collaborates with pharmacy benefit managers, entities responsible for managing drug formularies and overseeing prescription transactions, including the critical task of setting prices between consumers and pharmacies. The company was founded in 2015 and maintains its principal office in Santa Monica, California.
Key Executives
| Name | Position |
|---|---|
| Wendy Barnes | President, Chief Executive Officer & Director |
| Christopher A. McGinnis | Chief Financial Officer & Treasurer |
| Nitin Shingate | Chief Technology Officer |
| Vina Leite | Chief People Officer |
| Aaron Crittenden | Chief Revenue Officer & President of Rx Marketplace |
| Aubrey Reynolds | Director of Investor Relations |
| Douglas Joseph Hirsch | Co-founder & Director |
| Gracye Cheng | Senior Vice President, General Counsel & Secretary |
| Justin Fengler | Chief Strategy & Operations Officer, CFO and Treasurer |
| Scott Paul | Senior Vice President of Healthcare & Consumer Innovation |
| Thomas Chan | Chief Accounting Officer & Principal Accounting |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 26, 2026 | SC 13D/A | [Amend] Filing |
| Aug 26, 2026 | 4 | Filing |
| Aug 21, 2026 | 4 | Filing |
| Aug 17, 2026 | 4 | Filing |
| Aug 17, 2026 | 4 | Filing |
| Aug 12, 2026 | 4 | Filing |
| Aug 12, 2026 | 3 | Filing |
| Aug 05, 2026 | 8-K | Current Report |
| Aug 05, 2026 | 10-Q | Quarterly Report |
| Aug 05, 2026 | 8-K | Current Report |
GoodRx Inc.
| Country | United States |
| IPO Date | Sep 22, 2020 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 697 |
| CEO | Wendy Barnes |
Contact Details
2701 Olympic Boulevard Santa Monica,
California 90404 United States
Stock Details
| Ticker Symbol | GDRX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001809519 |
| CUSIP Number | 38246G108 |
| ISIN Number | US38246G1085 |
| SIC Code | 7374 |
Recent News
- 18 days ago / pymnts.comGoodRx Covers Whole Households and Pets in New Prescription Plan
- 1 month ago / seekingalpha.comGoodRx: Direct Brand Launches And New Subscription Plans Are Offering Hope
- 2 months ago / seekingalpha.comGoodRx Holdings, Inc. (GDRX) Q2 2026 Earnings Call Transcript
- 2 months ago / marketbeat.comGoodRx Q2 Earnings Call Highlights
- 2 months ago / pymnts.comGoodRx and Oscar Health Tout Tech as Consumer Needs Change
- 2 months ago / zacks.comGoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates
- 2 months ago / zacks.comGoodRx (GDRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
- 3 months ago / businesswire.comGoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call
- 3 months ago / zacks.comGoodRx (GDRX) Upgraded to Buy: What Does It Mean for the Stock?
- 3 months ago / zacks.comGDRX or HQY: Which Is the Better Value Stock Right Now?
Add to Watchlist
Select watchlists to add or remove GDRX